新诊断成人免疫性血小板减少症出血的危险因素及血小板计数阈值
这项多中心横断面研究纳入302例新诊断成人免疫性血小板减少症(ITP)患者,评估出血危险因素及血小板计数阈值。任何出血、黏膜出血和严重出血频率分别为57.9%、30.1%和6.6%。任何出血的最佳判别阈值为20×10⁹/L;血小板计数<10×10⁹/L与任何出血的OR为48.2(95%CI 20.0-116.3),抗凝药暴露与严重出血相关(OR 4.3,95%CI 1.3-14.1)。
要点
- 新诊断成人ITP任何出血、黏膜出血和严重出血频率分别为57.9%、30.1%和6.6%。
- 任何出血的最佳判别血小板阈值为20×10⁹/L。
- 血小板<10×10⁹/L与任何出血的OR为48.2(95%CI 20.0-116.3),抗凝药暴露与严重出血相关(OR 4.3,95%CI 1.3-14.1)。
核心结论
- 血小板计数<20×10⁹/L和<10×10⁹/L是任何出血和黏膜出血风险显著增加的血小板阈值。
- 血小板计数、女性性别和非甾体抗炎药(NSAIDs)暴露应被考虑用于评估任何出血的风险。
- 抗凝药物暴露是严重出血的主要危险因素。
研究设计与样本
- 多中心横断面研究,纳入CARMEN登记处和法国自身免疫性血细胞减少转诊中心的所有新诊断成人ITP患者,共302例。
- 评估ITP发病时任何出血、黏膜出血和严重出血(胃肠道、颅内或肉眼血尿)的频率,采用受试者工作特征曲线评估血小板计数阈值,并将所有潜在危险因素纳入逻辑回归模型。
主要发现
- 302例患者中,任何出血、黏膜出血和严重出血的频率分别为57.9%、30.1%和6.6%。
- 任何出血的最佳判别血小板计数阈值为20×10⁹/L。
- 多变量分析中,与任何出血相关的因素包括:血小板计数<10×10⁹/L对比≥20×10⁹/L(OR 48.2,95%CI 20.0-116.3);血小板计数10×10⁹/L至19×10⁹/L对比≥20×10⁹/L(OR 5.2,95%CI 2.3-11.6);女性性别(OR 2.6,95%CI 1.3-5.0);NSAIDs暴露(OR 4.8,95%CI 1.1-20.7)。
- 低血小板计数也是黏膜出血的主要危险因素。
- 抗凝药物暴露与严重出血相关(OR 4.3,95%CI 1.3-14.1)。
关键数值与推荐
- 任何出血的最佳判别血小板计数阈值为20×10⁹/L。
- 血小板计数<10×10⁹/L对比≥20×10⁹/L与任何出血的OR为48.2(95%CI 20.0-116.3)。
- 血小板计数10×10⁹/L至19×10⁹/L对比≥20×10⁹/L与任何出血的OR为5.2(95%CI 2.3-11.6)。
- 女性性别与任何出血的OR为2.6(95%CI 1.3-5.0);NSAIDs暴露与任何出血的OR为4.8(95%CI 1.1-20.7)。
- 抗凝药物暴露与严重出血的OR为4.3(95%CI 1.3-14.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Risk factors of bleeding in adult immune thrombocytopenia are not known. This multicenter study assessed risk factors of bleeding at immune thrombocytopenia onset. Platelet count thresholds associated with bleeding were < 20 × 109 L-1 and < 10 × 109 L-1 . Exposure to anticoagulants was a major risk factor of severe bleeding. SUMMARY: Background The aim of this cross-sectional study was to assess risk factors for bleeding in immune thrombocytopenia (ITP) adults, including the determination of platelet count thresholds. Methods We selected all newly diagnosed ITP adults included in the Cytopénies Auto-immunes Registre Midi-PyrénéEN (CARMEN) register and at the French referral center for autoimmune cytopenias. The frequencies of any bleeding, mucosal bleeding and severe bleeding (gastrointestinal, intracranial, or macroscopic hematuria) at ITP onset were assessed. Platelet count thresholds were assessed by the use of receiver operating characteristic curves. All potential risk factors were included in logistic regression models. Results Among the 302 patients, the frequencies of any, mucosal and severe bleeding were 57.9%, 30.1%, and 6.6%, respectively. The best discriminant threshold of platelet count for any bleeding was 20 × 109 L-1 . In multivariate analysis, factors associated with any bleeding were platelet count (< 10 × 109 L-1 versus ≥ 20 × 109 L-1 , odds ratio [OR] 48.2, 95% confidence interval [CI] 20.0-116.3; between 10 × 109 L-1 and 19 × 109 L-1 versus ≥ 20 × 109 L-1 , OR 5.2, 95% CI 2.3-11.6), female sex (OR 2.6, 95% CI 1.3-5.0), and exposure to non-steroidal anti-inflammatory drugs (NSAIDs) (OR 4.8, 95% CI 1.1-20.7). A low platelet count was also the main risk factor for mucosal bleeding. Exposure to anticoagulant drugs was associated with severe bleeding (OR 4.3, 95% CI 1.3-14.1). Conclusions Platelet counts of < 20 × 109 L-1 and < 10 × 109 L-1 were thresholds for major increased risks of any and mucosal bleeding. Platelet count, female sex and exposure to NSAIDs should be considered for assessment of the risk of any bleeding. Exposure to anticoagulant drugs was a major risk factor for severe bleeding.
引用
- Piel-Julian ML, Mahévas M, Germain J, et al. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults. J Thromb Haemost. 2018. PMID: 29978544. doi:10.1111/jth.14227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。